Ipamorelin is a synthetic peptide studied as a selective growth hormone secretagogue.

It acts through the ghrelin-related growth hormone secretagogue receptor pathway and has been investigated for its effects on pituitary growth hormone release.

Commonly researched areas of interest

• Growth hormone secretagogue receptor signalling

• Ghrelin-related pathways

• Pituitary growth hormone release

• Endocrine response patterns

• Peptide pharmacokinetics

• Relationships between peptide exposure and hormone response

Human pharmacology research has investigated Ipamorelin’s effects on growth hormone release. These findings do not establish clinical benefits or demonstrate that the product has minimal side effects.

For research use only. Not for human consumption.